CHICAGO--(BUSINESS WIRE)--CytoCore Inc. (OTCBB:CYCR), the biopharmaceutical research and medical device company for early detection and treatment of reproductive-tract cancers, today announced that Dr. Michael Jolley has joined CytoCore as its Director of Assay Development.
Dr. Jolley’s scientific background includes expertise in areas related to systems integration, and the co-development of assays and instrumentation. His work has led to the commercial success of a number of immunoassay systems.
